Related references
Note: Only part of the references are listed.Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
Pier Luigi Zinzani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation
Lijun Shen et al.
BLOOD (2007)
A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors
Jens Voortman et al.
CLINICAL CANCER RESEARCH (2007)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Proteasome inhibition with bortezomib: A new therapeutic strategy for non-Hodgkin's lymphoma
John P. Leonard et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy
J Lee et al.
EUROPEAN JOURNAL OF CANCER (2005)
Nasal-type NK/T cell lymphoma: clinical features and treatment outcome
J Lee et al.
BRITISH JOURNAL OF CANCER (2005)
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-Cell non-Hodgkin's lymphoma
A Goy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer
CN Papandreou et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma
LJ Shen et al.
BLOOD (2003)
CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
WS Kim et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
